Eltrombopag for the treatment of aplastic anemia: current perspectives
Su Han Lum, John D GraingerDepartment of Blood and Marrow Transplant, Royal Manchester Children’s Hospital, Manchester, UK Abstract: Aplastic anemia (AA) is a potential life-threatening hematopoietic stem cell (HSC) disorder resulting in cytopenia. The mainstays of treatment for AA are def...
Saved in:
Main Authors: | Lum SH (Author), Grainger JD (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of eltrombopag in severe aplastic anemia treatment in children
by: Min-Yu Su, et al.
Published: (2021) -
Aplastic Anemia Treated with Eltrombopag during Pregnancy
by: Yuri Suminaga, et al.
Published: (2022) -
Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia
by: Yufei Zhao, et al.
Published: (2023) -
Budget Impact Of Eltrombopag As First-Line Treatment For Severe Aplastic Anemia In The United States
by: Tremblay G, et al.
Published: (2019) -
The efficacy and the safety of eltrombopag in pediatric patients with severe aplastic anemia: a systematic review
by: Maria Maddalena Marrapodi, et al.
Published: (2023)